Beth M. Beadle

Palo Alto University, Stanford University

Papers

Total Citations

H-Index

About

Beth M. Beadle is a leading radiation oncologist whose research focuses on the intersection of treatment efficacy, cost-effectiveness, and quality of life in head and neck cancers, particularly oropharyngeal carcinoma (OPC). Her work has been instrumental in shaping modern clinical decision-making, especially in comparing the financial and clinical outcomes of chemoradiation versus transoral robotic surgery (TORS). Her highly cited 2018 study, "Cost comparison of treatment for oropharyngeal carcinoma" (21 citations), provides critical data for clinicians and policymakers navigating treatment options in an era of rising healthcare costs. Beadle has also been a key voice in highlighting the transformative impact of HPV testing on oropharyngeal cancer demographics and management, as seen in her 2017 commentary "The impact of HPV testing for oropharyngeal cancers: Why the addendum matters." By addressing the shift from a disease of older, heavy smokers to one increasingly affecting younger, healthier patients, her work underscores the need for personalized, value-based care. Through her research, Beadle continues to influence how head and neck cancers are staged, treated, and discussed in both clinical and health-economic contexts.